RZ
RZLVW
REZOLVE AI PLC
$0.8086
-22.25%
$323.3M
No data for this timeframe.
Vol
Market Cap$323.3M
Cap SizeSmall Cap
SEC Reports6
Exchange Nasdaq·Sector Services-Computer Programming, Data Processing, Etc.·Inc. X0·CIK 0001920294·Prev Close $1.04
Recent Activity
Jun 5, 2026
SEC
Rezolve AI filed a 6-K on June 5, 2026, disclosing two items: (1) a Waiver Deed with sellers of Reward Loyalty UK Limite
6-K — Impact 5/10
Apr 30, 2026
SEC
Rezolve AI reported $60M in Q1 2026 revenue (unaudited), exceeding its full-year 2025 audited revenue of $46.8M in just
6-K — Impact 7/10
Apr 29, 2026
SEC
Rezolve AI escalates its hostile bid for Commerce.com by distributing a flyer at the Commerce Live conference, directly
425, 6-K — Impact 7/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 5 bullish, 0 bearish, 1 mixed, 0 neutral. Avg impact: 6.7/10.
MIXED
6-K
5/10
Rezolve AI filed a 6-K on June 5, 2026, disclosing two items: (1) a Waiver Deed with sellers of Rewa
Jun 5, 2026
BULLISH
6-K
7/10
Rezolve AI reported $60M in Q1 2026 revenue (unaudited), exceeding its full-year 2025 audited revenu
Apr 30, 2026
BULLISH
425, 6-K
7/10
Rezolve AI escalates its hostile bid for Commerce.com by distributing a flyer at the Commerce Live c
Apr 29, 2026
BULLISH
425, 6-K
7/10
Rezolve AI is aggressively pursuing an unsolicited acquisition of Commerce.com after the target's bo
Apr 15, 2026
BULLISH
425
7/10
Rezolve AI PLC is escalating its unsolicited bid to acquire Commerce.com after the target's board re
Apr 13, 2026
BULLISH
6-K
7/10
Rezolve AI plc announced an upcoming investor call to discuss its proposed combination with Commerce
Apr 13, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 661.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.5B | 52.5% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.